Zevra Therapeutics, Inc. (ZVRA) Stock News & Chart | StockAdder

(ZVRA)

Zevra Therapeutics, Inc.

Stock chart and latest news for Zevra Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Zevra Therapeutics, Inc. News

PRO

ZVRA SEC Filings - Zevra Therapeutics Inc 10-K, 10-Q, 8-K Forms

Apr 9, 2026 Yahoo Finance

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) is definitely on the radar of institutional investors who own 50% of the company

Oct 30, 2025 Investing.com

Guggenheim raises Zevra Therapeutics stock price target to $23

Mar 10, 2026 The Motley Fool

Why Zevra Therapeutics Stock Zoomed 21% Higher Today

Mar 10, 2026 Trefis

Zevra Therapeutics Stock Pre-Market (+17%): Reports Massive Q4 EPS Beat

Mar 10, 2026 simplywall.st

Profit Swing, MIPLYFFA Uptake and New CFO Might Change The Case For Investing In Zevra Therapeutics (ZVRA)

Mar 10, 2026 Yahoo Finance

Is Zevra Therapeutics (ZVRA) Pricing Reflecting Its Strong Multi‑Year Share Price Performance

Mar 11, 2026 Investing.com

BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook

Mar 16, 2026 Yahoo Finance

Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress?

Dec 14, 2025 Stock Titan

Zevra Therapeutics (NASDAQ: ZVRA) posts $106.5M 2025 revenue; proxy items

Apr 6, 2026 Yahoo Finance

What To Expect From Zevra Therapeutics Inc (ZVRA) Q3 2025 Earnings

Nov 4, 2025 Stock Titan

New Zevra finance chief gets a 300,000-share stock option